Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis.

BACKGROUND: Non-small cell lung cancer (NSCLC) is the most common form of lung cancer. Some epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutations make tumours responsive to treatment with EGFR-TK inhibitors (EGFR-TKIs) but less responsive to treatment with standard chemotherapy. Patie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Health Technol Assess
Autors principals: Westwood, Marie, Joore, Manuela, Whiting, Penny, van Asselt, Thea, Ramaekers, Bram, Armstrong, Nigel, Misso, Kate, Severens, Johan, Kleijnen, Jos
Format: Artigo
Idioma:Inglês
Publicat: NIHR Journals Library 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4781337/
https://ncbi.nlm.nih.gov/pubmed/24827857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta18320
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars